Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Boston Scientific begins Maps enrolment

Boston Scientific begins Maps enrolment

3rd April 2007

Medical devices firm Boston Scientific confirmed that it has commenced enrolment for a clinical trial investigating the treatment of brain aneurysms.

The Matrix And Platinum Science (Maps) project is recruiting volunteers for its research work, which involves measuring the effectiveness of endovascular therapies for cerebral aneurysms, reports Medical News.

According to Boston Scientific, which manufactures detachable coils for use on people with a brain aneurysm, the trial’s first patient has already undergone treatment at St Joseph’s Hospital in Minnesota.

“It is gratifying to achieve this milestone of first patient enrolment,” commented Dr Cameron McDougall, head of endovascular neurosurgery at the Barrow Neurological Institute and co-principal investigator of the Maps project.

He added that the trial is both vital in its own right as well as further demonstrating that “multidisciplinary aneurysm trials can and will help define the future of aneurysm treatment”.

Volunteers enrolled on the study will be selected randomly to receive treatment comprising either Matrix2 or GDC detachable coils.

Some 630 patients are expected to undergo treatment in about 50 different locations as part of the clinical trial.

Endovascular therapy involves accessing the damaged area of the brain through coil embolisation of the blood vessels and is achieved using X-ray machinery rather than open surgery.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.